Please keep checking this site for possible updates.

Research News

Almost all men with early prostate cancer survive 10 years, regardless of treatment

November 11, 2016

The survival rate for early-stage prostate cancer is 99 percent after 10 years, regardless of whether men undergo surgery, radiation or are “actively monitored,” according to studies published Wednesday. Researchers hailed the results as good news, saying they had been expecting a survival rate of 90 percent. This article is hopeful, but leaves questions.  It’s […]

Read the article or watch the video →

Acne Bacteria Plays A Role In Prostate Cancer

October 23, 2016

In a Swedish study, a bacterial species, Propionibacterium acnes, was found in 60 per cent of the prostate cancer biopsies, as opposed to 26 per cent of the controls. Read the article here.

Read the article or watch the video →

Revolutionary new cancer treatment makes patients SIX TIMES more likely to survive

September 13, 2016

A revolutionary new DNA treatment technique involves having a simple DNA test of your tumour first. This then tells doctors precisely which drugs or therapies are most suited to you – rather than relying on the standard treatment. The genetic profiling of your tumour can also tell doctors which drugs you should avoid because they […]

Read the article or watch the video →

Advances in targeted radiation for prostate cancer

September 13, 2016

A clinical trial at Sunnybrook Hospital in Toronto will determine the effectiveness of a targeted radiotherapy approach, stereotactic body radiotherapy (SBRT), in improving outcomes for men with oligometastatic prostate cancer. Read the article.

Read the article or watch the video →

Cholesterol-Lowering Agent Halts Prostate Cancer

September 13, 2016

A compound initially developed as a cholesterol-fighting agent not only halts the progression of prostate cancer, but also can kill cancerous cells, researchers at the University of Missouri have determined. Read the article.

Read the article or watch the video →

Clinical trial will test use of MRI to improve prostate cancer diagnosis and management

September 13, 2016

The Movember Foundation, the Ontario Institute for Cancer Research and Prostate Cancer Canada announced $3 million in funding for a new Phase III clinical trial to evaluate if magnetic resonance imaging (MRI) can replace the current standard of care to diagnose prostate cancer. The primary objective is to determine whether MRI imaging can spare some […]

Read the article or watch the video →

Quality of life meets cure for prostate cancer treatment

September 13, 2016

A new paper looks at how MRI and a clear understanding of the functional anatomy around the prostate can allow radiation oncologists to plan a course of treatment for patients with prostate cancer that spares these critical structures. Read the article.

Read the article or watch the video →

A Breakthrough Test for Prostate Cancer

September 13, 2016

Every four minutes, prostate cancer kills someone, somewhere around the world. Researchers at Cambridge Oncometrix, are developing a simple test that will detect the disease early. Dmitry Soloviev is one the scientists who’s helping to develop a test that can indicate the presence of cancer cells. Dr. Dmitry is the principal scientist at Oncometrix. Watch […]

Read the article or watch the video →

Video: “Imaging Tests”

August 23, 2016

July 2016 Awareness Night Imaging Tests Dr. Masoom Haider, MD, FRCPC Senior scientist, Physical Sciences, Odette Cancer Research Program Sunnybrook Research Institute Chief, Department of medical imaging, Sunnybrook Health Sciences Centre Professor, Department of medical imaging, University of Toronto Clinician scientist, Ontario Institute for Cancer Research   CLICK ON THE ARROW TO START THE VIDEO […]

Read the article or watch the video →

Questions to Ask Before Participating in a Prostate Cancer Clinical Trial

July 24, 2016

Several key questions that a participant will want answered before enrolling in a clinical trial are listed here. It is important that people learn as much as possible prior to entering a trial, and to thoroughly discuss the study with a doctor and with the study team. Read the article.

Read the article or watch the video →